188 related articles for article (PubMed ID: 32196951)
1. Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model.
Wang J; Li Y; Li L; Yang J; Kopeček J
Macromol Biosci; 2020 May; 20(5):e1900445. PubMed ID: 32196951
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo.
Tommy Gambles M; Li J; Christopher Radford D; Sborov D; Shami P; Yang J; Kopeček J
J Control Release; 2022 Oct; 350():584-599. PubMed ID: 36037975
[TBL] [Abstract][Full Text] [Related]
3. Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.
Zhang L; Fang Y; Yang J; Kopeček J
J Control Release; 2017 Oct; 263():139-150. PubMed ID: 28024916
[TBL] [Abstract][Full Text] [Related]
4. Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine.
Wang J; Li L; Yang J; Clair PM; Glenn MJ; Stephens DM; Radford DC; Kosak KM; Deininger MW; Shami PJ; Kopeček J
Nanomedicine; 2019 Feb; 16():217-225. PubMed ID: 30639670
[TBL] [Abstract][Full Text] [Related]
5. Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors.
Li J; Gambles MT; Jones B; Williams JA; Camp NJ; Shami PJ; Yang J; Kopeček J
Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38802679
[TBL] [Abstract][Full Text] [Related]
6. Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells.
Gambles MT; Li J; Wang J; Sborov D; Yang J; Kopeček J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361811
[TBL] [Abstract][Full Text] [Related]
7. Obinutuzumab-Based Drug-Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors.
Gambles MT; Sborov D; Shami P; Yang J; Kopeček J
Macromol Biosci; 2024 Mar; 24(3):e2300375. PubMed ID: 37838941
[TBL] [Abstract][Full Text] [Related]
8. Drug-free macromolecular therapeutics exhibit amplified apoptosis in G2/M phase arrested cells.
Li L; Yang J; Wang J; Kopeček J
J Drug Target; 2019; 27(5-6):566-572. PubMed ID: 30198798
[TBL] [Abstract][Full Text] [Related]
9. Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics.
Li L; Yang J; Wang J; Kopeček J
ACS Nano; 2018 Apr; 12(4):3658-3670. PubMed ID: 29595951
[TBL] [Abstract][Full Text] [Related]
10. Biorecognition: A key to drug-free macromolecular therapeutics.
Yang J; Li L; Kopeček J
Biomaterials; 2019 Jan; 190-191():11-23. PubMed ID: 30391799
[TBL] [Abstract][Full Text] [Related]
11. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity.
Yanaba K; Hamaguchi Y; Venturi GM; Steeber DA; St Clair EW; Tedder TF
J Immunol; 2007 Jul; 179(2):1369-80. PubMed ID: 17617630
[TBL] [Abstract][Full Text] [Related]
12. Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
Hamel K; Doodes P; Cao Y; Wang Y; Martinson J; Dunn R; Kehry MR; Farkas B; Finnegan A
J Immunol; 2008 Apr; 180(7):4994-5003. PubMed ID: 18354225
[TBL] [Abstract][Full Text] [Related]
13. B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis.
Brühl H; Cihak J; Talke Y; Rodriguez Gomez M; Hermann F; Goebel N; Renner K; Plachý J; Stangassinger M; Aschermann S; Nimmerjahn F; Mack M
Eur J Immunol; 2015 Mar; 45(3):705-15. PubMed ID: 25471597
[TBL] [Abstract][Full Text] [Related]
14. Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.
Chu TW; Yang J; Zhang R; Sima M; Kopeček J
ACS Nano; 2014 Jan; 8(1):719-30. PubMed ID: 24308267
[TBL] [Abstract][Full Text] [Related]
15. Human Serum Albumin-Based Drug-Free Macromolecular Therapeutics: Apoptosis Induction by Coiled-Coil-Mediated Cross-Linking of CD20 Antigens on Lymphoma B Cell Surface.
Zhang L; Fang Y; Li L; Yang J; Radford DC; Kopeček J
Macromol Biosci; 2018 Nov; 18(11):e1800224. PubMed ID: 30259654
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody.
Maeda T; Saikawa I; Hotokebuchi T; Sugioka Y; Eto M; Murakami Y; Nomoto K
Arthritis Rheum; 1994 Mar; 37(3):406-13. PubMed ID: 8129796
[TBL] [Abstract][Full Text] [Related]
17. CD44 involvement in experimental collagen-induced arthritis (CIA).
Nedvetzki S; Walmsley M; Alpert E; Williams RO; Feldmann M; Naor D
J Autoimmun; 1999 Aug; 13(1):39-47. PubMed ID: 10441166
[TBL] [Abstract][Full Text] [Related]
18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
19. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
Pers YM; Jorgensen C
Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
[TBL] [Abstract][Full Text] [Related]
20. The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model.
Quan L; Zhang Y; Dusad A; Ren K; Purdue PE; Goldring SR; Wang D
Pharm Res; 2016 Jan; 33(1):186-93. PubMed ID: 26286188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
